Exagen (XGN) Return on Capital Employed (2019 - 2026)

Exagen (XGN) has 8 years of Return on Capital Employed data on file, last reported at 33.28% in Q1 2026.

• Quarterly Return on Capital Employed rose 1584.0% year-over-year to 33.28% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 33.28% (up 1584.0% YoY) and the FY2025 annual result came in at 37.83%, down 128.0% from the prior year.
• Return on Capital Employed slipped to 33.28% in Q1 2026, from 30.41% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 25.42% in Q1 2022 to a low of 61.37% in Q3 2023.
• A 5-year average of 42.36% and a median of 40.71% in 2022 frame the typical range for Return on Capital Employed.
• Annual changes were most pronounced in 2023 — Return on Capital Employed slumped 3458 bps — and 2024, when it soared 2050 bps.
• Tracing XGN's Return on Capital Employed over 5 years: stood at 54.64% in 2022, then advanced by 11 bps to 48.55% in 2023, then rose by 8 bps to 44.5% in 2024, then soared by 32 bps to 30.41% in 2025, then slipped by 9 bps to 33.28% in 2026.
• The last three Return on Capital Employed figures came in at 33.28% (Q1 2026), 30.41% (Q4 2025), and 26.05% (Q3 2025), per Business Quant data.